TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Octapharma Nordic AB
Closing information (x1000 NOK)
| Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Turnover |
36,709,878
|
30,024,840
|
25,090,674 |
| Financial expenses |
20,503
|
35,380
|
212,062 |
| Earnings before taxes |
4,948,539
|
5,385,096
|
4,719,233 |
| EBITDA |
6,530,541
|
6,854,481
|
6,336,517 |
| Total assets |
49,826,927
|
44,560,567
|
38,725,095 |
| Current assets |
36,851,003
|
31,870,450
|
27,137,720 |
| Current liabilities |
4,671,953
|
4,199,969
|
3,907,272 |
| Equity capital |
43,058,973
|
38,096,082
|
32,903,498 |
| - share capital |
1,349
|
1,263
|
1,200 |
| Employees (average) |
10,587
|
9,734
|
8,336 |
Financial ratios
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Solvency |
86.4%
|
85.5%
|
85.0% |
| Turnover per employee |
3,467
|
3,085
|
3,010 |
| Profit as a percentage of turnover |
13.5%
|
17.9%
|
18.8% |
| Return on assets (ROA) |
10.0%
|
12.2%
|
12.7% |
| Current ratio |
788.8%
|
758.8%
|
694.5% |
| Return on equity (ROE) |
11.5%
|
14.1%
|
14.3% |
| Change turnover |
4,554,567
|
5,688,247
|
1,670,654 |
| Change turnover % |
14%
|
23%
|
7% |
| Chg. No. of employees |
853
|
1,398
|
195 |
| Chg. No. of employees % |
9%
|
17%
|
2% |
Total value of public sale
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.